22nd Century Group Inc (NASDAQ:XXII)

2.90
Delayed Data
As of Oct 15
 -0.05 / -1.69%
Today’s Change
0.68
Today|||52-Week Range
6.07
+31.82%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$541.9M

Company Description

22nd Century Group, Inc. is a biotechnology company, which develops disruptive plant-based solutions for life science, consumer product, and pharmaceutical markets. It focuses on technologies that alter the level of nicotine in tobacco plants and level of cannabinoids in hemp or cannabis plants through genetic engineering, gene-editing, and modern plant breeding techniques. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.

Contact Information

22nd Century Group, Inc.
500 Seneca Street
Buffalo New York 14204
P:(716) 270-1523
Investor Relations:
(716) 300-1221

Employees

Chart unavailable

Shareholders

Mutual fund holders21.12%
Other institutional14.33%
Individual stakeholders13.94%

Top Executives

James A MishChief Executive Officer
Michael J. ZercherPresident & Chief Operating Officer
John E. FranzinoChief Financial Officer & VP-Administration
Juan Sanchez TamburrinoVice President-Research & Development
Steven P. PrzybylaSecretary, Vice President & General Counsel